会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • High-strength steel sheet with excellent low temperature toughness and manufacturing thereof
    • 具有优异的低温韧性的高强度钢板及其制造方法
    • US08647564B2
    • 2014-02-11
    • US12746073
    • 2008-11-12
    • Seong Soo AhnJang Yong YooKi Ho KimChoong Jae ParkTae Woo Lee
    • Seong Soo AhnJang Yong YooKi Ho KimChoong Jae ParkTae Woo Lee
    • C22C38/00C21D8/02
    • C22C38/001C21D6/005C21D8/0205C21D2211/001C21D2211/002C21D2211/005C21D2211/008C22C38/06C22C38/12C22C38/14
    • There is provided a high-strength steel plate having acicular ferrite and bainite as a main microstructure and an austenite/martensite (M & A) as a second phase under the control of a cooling rate above the austenite transformation temperature. The high-strength steel plate comprises: carbon (C): 0.03 to 0.10 wt %, silicon (Si): 0.1 to 0.4 wt %, manganese (Mn): 1.8 wt % or less, nickel (Ni): 1.0 wt % or less, titanium (Ti): 0.005 to 0.03 wt %, niobium (Nb): 0.02 to 0.10 wt %, aluminum (Al): 0.01 to 0.05 wt %, calcium (Ca): 0.006 wt % or less, nitrogen (N): 0.001 to 0.006 wt %, phosphorus (P): 0.02 wt % or less, sulfur (S): 0.005 wt % or less, and the balance of iron (Fe) and other inevitable impurities. The method for manufacturing a high-strength steel plate may be useful to economically and effectively manufacture a high strength steel, which is able to secure excellent properties such as high strength and high toughness since the acicular ferrite and bainite may be effectively formed without adding expensive elements such as molybdenum (Mo).
    • 在奥氏体转变温度以上的冷却速度的控制下,提供了具有针状铁素体和贝氏体作为主要组织的高强度钢板和作为第二相的奥氏体/马氏体(M&A)。 高强度钢板包括:碳(C):0.03〜0.10重量%,硅(Si):0.1〜0.4重量%,锰(Mn):1.8重量%以下,镍(Ni):1.0重量% 较少,钛(Ti):0.005〜0.03重量%,铌(Nb):0.02〜0.10重量%,铝(Al):0.01〜0.05重量%,钙(Ca):0.006重量% :0.001〜0.006重量%,磷(P):0.02重量%以下,硫(S):0.005重量%以下,余量由铁(Fe)等不可避免的杂质构成。 制造高强度钢板的方法可有效地经济有效地制造能够确保高强度和高韧性的优异性能的高强度钢,因为可以有效地形成针状铁素体和贝氏体而不增加昂贵的 元素如钼(Mo)。
    • 5. 发明授权
    • Video device and control method thereof
    • 视频设备及其控制方法
    • US08442223B2
    • 2013-05-14
    • US11357132
    • 2006-02-21
    • Ki-ho KimEun-kyung KangDo-young Kim
    • Ki-ho KimEun-kyung KangDo-young Kim
    • H04N7/167H04N7/173H04N7/16
    • H04N7/17318H04N21/6118H04N21/6168H04N21/8355
    • A video device for determining whether a digital broadcasting channel through a point of deployment (POD) is reproduced, includes a memory; a communicator to communicate with the POD; a controller which stores a first copy control information (CCI) value with respect to a first digital broadcasting channel in the memory, if converting the first digital broadcasting channel into an analog broadcasting channel, and sets the first CCI value stored in the memory to a second CCI value with respect to a second digital broadcasting channel if the second CCI value is not received through the communicator from the POD and if converting the analog broadcasting channel into the second digital broadcasting channel.
    • 用于确定通过部署点(POD)的数字广播频道是否被再现的视频装置包括存储器; 与POD沟通的沟通者; 如果将第一数字广播频道转换为模拟广播频道,则将存储器中的第一数字广播频道的第一复制控制信息(CCI)值存储在存储器中,并将存储在存储器中的第一CCI值设置为 如果没有通过来自POD的通信器接收到第二CCI值,并且如果将模拟广播信道转换成第二数字广播信道,则相对于第二数字广播信道的第二CCI值。
    • 10. 发明申请
    • COMPOSITION FOR TREATING OR PREVENTING AMYLOID-RELATED DISEASES COMPRISING 4-O-METHYLHONOKIOL
    • 用于治疗或预防包含4-O-甲基胆碱的与淀粉样相关疾病的组合物
    • US20110207830A1
    • 2011-08-25
    • US13120818
    • 2009-09-25
    • Ki Ho KimKi Soo KimYoung Heui KimJin Guk KimKyoung Tae KimChang Sung HanSang iL Lee
    • Ki Ho KimKi Soo KimYoung Heui KimJin Guk KimKyoung Tae KimChang Sung HanSang iL Lee
    • A61K31/075A61P25/28A61P25/00
    • A61K31/085A23L2/52A23L33/105A61K31/05A61K36/575
    • Disclosed is a composition for treating or preventing amyloid-related diseases including 4-O-methylhonokiol as an active ingredient. More specifically, a pharmaceutical composition including 4-O-methylhonokiol, which is effective for treating or preventing amyloid-related diseases such as Alzheimer's disease, cognitive disorder, defective memory, amyloidosis, etc. is disclosed. The inventors of the present disclosure have found out for the first time that 4-O-methylhonokiol inhibits the production of β-amyloid. It has been confirmed to be useful in treating or preventing amyloid-related diseases. Through animal tests including water maze test and passive avoidance test on mice, 4-O-methylhonokiol has been confirmed to be effective for amyloid-related diseases such as Alzheimer's disease, defective memory, cognitive disorder, and the like. It was further confirmed through acetylcholinesterase activity inhibition test using mouse brain cortex and hippocampus tissue that they are particularly effective in treating or preventing Alzheimer's disease among the amyloid-related diseases.
    • 公开了用于治疗或预防淀粉样蛋白相关疾病的组合物,包括4-O-甲基联苯甲醇作为活性成分。 更具体地说,公开了一种药物组合物,其包含对于治疗或预防淀粉样蛋白相关疾病如阿尔茨海默氏病,认知障碍,缺陷记忆,淀粉样变性等有效的4-O-甲基联苯甲醇。 本公开的发明人首次发现4-O-甲基胡酮醇抑制β-淀粉样蛋白的产生。 已经证实可用于治疗或预防淀粉样蛋白相关疾病。 通过动物试验,包括水迷宫试验和小鼠被动回避试验,已证实4-O-甲基黑叶醇对淀粉样蛋白相关疾病如阿尔茨海默病,记忆缺陷,认知障碍等有效。 通过使用小鼠脑皮层和海马组织的乙酰胆碱酯酶活性抑制试验进一步证实,它们在淀粉样蛋白相关疾病中治疗或预防阿尔茨海默氏病方面特别有效。